ASCO!

Lucy attended the ASCO Annual Scientific Meeting in Chicago, and presented the The WinPro trial: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive breast cancer. As part of her PhD, Lucy is now using spatial transcriptomics technolgoies to analyse samples from the WinPro trial to uncover new mechanistic insights in HR+ breast cancer.